Article
Targeted NAD+ Delivery for Intimal Hyperplasia and Re-endothelialization: A Novel…
medRxiv · 2024 · Yin, L.; Tong, Y.; Islam, Z. H.; Zhang, K.; Xie, R.; Burger, J.; Hoyt, N.; Kent, E. W.; Marcum, W. A.; Johnston, C.; Kanchetty, R.; Tetz, Z.; Stanisic, S.; Huang, Y.; Guo, L.-W.; Gong, S.; Wang, B.
Key facts
| Title | Targeted NAD+ Delivery for Intimal Hyperplasia and Re-endothelialization: A Novel Anti-restenotic Therapy Approach |
|---|---|
| First author | Yin, L.; Tong, Y.; Islam, Z. H.; Zhang, K.; Xie, R.; Burger, J.; Hoyt, N.; Kent, E. W.; Marcum, W. A.; Johnston, C.; Kanchetty, R.; Tetz, Z.; Stanisic, S.; Huang, Y.; Guo, L.-W.; Gong, S.; Wang, B. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.02.20.581249 |
| Product codes mentioned | KIP, KIT, LEA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1